|
시장보고서
상품코드
2058193
시퀀싱 시약 시장 : 제품 유형별, 시퀀싱 유형별, 워크플로우별, 용도별, 최종 사용자별, 지역별Sequencing Reagents Market, By Product Type, By Sequencing Type, By Workflow, By Application, By End User, By Geography |
||||||
시퀀싱 시약 시장은 2026년에 113억 달러에 달하고 2033년까지 348억 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR은 17.5%를 나타낼 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모(2026년) : | 113억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 17.50% | 시장 규모 예측(2033년) : | 348억 달러 |
임상 진단, 생식 건강 검진, 감염증 검사, 종양학 검사, 분자진단 등 각 분야에서 1세대 및 2세대 차세대 염기서열 분석(NGS) 기술의 활용이 확대됨에 따라 시장은 눈부신 성장을 이루고 있습니다. 라이브러리 조제 키트, 증폭 시약, 효소, 뉴클레오티드, 소모품 등의 시퀀싱 시약은 제약 및 생명공학 기업, 학술 기관, 그리고 병원 검사실에서 진행되는 유전체 분석 과정의 다양한 단계에서 사용되고 있습니다.
유전성 질환 및 암 발병률 증가와 더불어, 유전체 연구 및 분자진단에 대한 자금 투자의 확대가 시장 성장을 뒷받침하는 주요 요인으로 작용하고 있습니다. 또한, 롱 리드 시퀀싱, 단일 세포 유전체학, 자동 시퀀싱 플랫폼 분야의 최근 기술적 진보로 인해 시퀀싱 워크플로의 정확성과 효율성이 향상되고 있습니다. 정부 차원의 유전체 의료 프로그램에 대한 지원 확대와 바이오마커 발견, 그리고 맞춤형 의료 분야에서 시퀀싱 기술의 응용 분야 확대는 전 세계 시퀀싱 시약 시장에 장기적인 성장 기회를 가져다줄 것으로 전망됩니다.
시장 역학
세계 시퀀싱 시약 시장은 임상 진단, 종양학, 감염병 검사 및 맞춤형 의료 분야에서 유전체 시퀀싱 기법의 활용이 확대됨에 따라 눈부신 성장을 이루고 있습니다. 암, 유전성 질환 및 기타 만성 질환의 유병률 증가는 유전체 분석을 위한 차세대 염기서열 분석(NGS) 과정에 대한 수요의 급속한 확대를 이끌고 있습니다. 또한, 제약 회사, 생명공학 기업 및 연구 기관의 유전체학 및 바이오마커 연구에 대한 투자가 전 세계 시퀀싱 시약 시장의 급속한 성장을 견인하고 있습니다. 또한, 맞춤형 의료의 이용 확대와 생식 의학 및 희귀질환 진단 분야에서 시퀀싱 기술의 적용 범위 확대 역시 전 세계 시퀀싱 시약 산업의 성장을 뒷받침하고 있습니다.
그러나 업계 분석가들은 예측 기간 동안 시장 성장을 저해할 몇 가지 요인이 있을 것으로 전망하고 있습니다. 현재, 시퀀싱 워크플로우, 장비 및 전문적인 생물정보학 인프라의 높은 비용이 개발도상국의 중소규모 연구소에서 해당 제품을 도입하는 데 걸림돌이 되고 있습니다. 또한, 유전체 데이터의 저장 및 분석, 해석자의 지식 격차와 같은 실용화와 관련된 문제들은 업계 관계자들이 숙련된 인력과 최첨단 컴퓨팅 자원을 확보해야 하는 과제를 안겨주고 있습니다. 임상 유전체 검사와 관련된 규제 당국의 기타 과제 및 특정 지역의 보험 급여 제한은 여전히 주요 우려 사항으로 남아 있습니다. 그러나 롱 리드 시퀀싱, 단일 세포 응용 분야, 그리고 시퀀싱 워크플로우 자동화 분야의 발전은 업계에 새로운 성장 기회를 가져다줄 것으로 기대됩니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 세계 시퀀싱 시약 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로는 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략입니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 보고서는 세계의 시퀀싱 시약 시장에 관한 것으로, 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 시퀀싱 시약 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적 및 전제 조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 시퀀싱 시약 시장 : 제품 유형별(2021-2033년)
제5장 세계의 시퀀싱 시약 시장 : 시퀀싱 유형별(2021-2033년)
제6장 세계의 시퀀싱 시약 시장 : 워크플로우별(2021-2033년)
제7장 세계의 시퀀싱 시약 시장 : 용도별(2021-2033년)
제8장 세계의 시퀀싱 시약 시장 : 최종 사용자별(2021-2033년)
제9장 세계의 시퀀싱 시약 시장 : 지역별(2021-2033년)
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 참고 문헌 및 조사 방법
KTH 26.06.19Sequencing Reagents Market is estimated to be valued at USD 11.3 Bn in 2026 and is expected to reach USD 34.8 Bn by 2033, growing at a compound annual growth rate (CAGR) of 17.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 11.3 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 17.50% | 2033 Value Projection: | USD 34.8 Bn |
The market is witnessing huge growth with ascension in use of first- and second-generation Next Generation Sequencing (NGS) techniques across clinical diagnostics, reproductive health screening, infectious disease testing, oncology research and molecular diagnostics. Sequencing Reagents such as library prep kits, amplification reagents, enzymes, nucleotides and consumables are used at various stages of genome analysis process which is used by pharmaceutical & biotech companies, academic institutions and by hospital laboratories.
The increasing incidence of genetic conditions and cancer combined with increasing funding in genomics research and molecular diagnostics are primary drivers in supporting market growth. Moreover, recent technological advances in long-read sequencing, single cell genomics and automated sequencing platforms are improving the accuracy and efficiency of sequencing workflows. Expanding government support for genomic medicine programs and growing application areas of sequencing technologies in biomarker discovery and personalized therapeutics are likely to present long-term growth opportunities for the global sequencing reagents market.
Market Dynamics
The global sequencing reagents market is witnessing substantial growth owing to the growing use of genomic sequencing approaches in clinical diagnostics, oncology, infectious disease testing and personalized medicine. The increasing prevalence of cancer, genetic, and other long-term diseases has driven a rapid growing demand for Next Generation Sequencing (NGS) processes for genomic analyses. Besides, investments by pharmaceutical, biotech companies and research facilities in genomics and biomarker research are driving a rapid growth of sequencing reagents in the world. The growing use of customized medicine and the broadening application of sequencing techniques in reproductive health and rare diseases diagnostics are also boosting the growth of sequencing reagents industry globally.
However, industry analysts anticipate some factors which will constrain the market growth during the forecast period. Currently, the high cost of sequencing workflows, instrumentation and specialized bioinformatics infrastructure prohibits acceptance of product within small and medium-sized laboratories in less-developed economies. Moreover, problems faced by industry players in relation to practical application of genomic data such as storage, analysis and the gap of knowledge of interpreters necessitate the employment of a skilled workforce and cutting-edge computing resources. Other issues posed by regulatory body concerning clinical genomic testing and reimbursement limitations in certain regions persists to be a key concern. But, advances in long-read sequencing, single-cell applications and automation of sequencing workflows are expected to present novel growth opportunities to the industry.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global sequencing reagents market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Illumina, Thermo Fisher Scientific, QIAGEN, F. Hoffmann-La Roche, Pacific Biosciences, Oxford Nanopore Technologies, Agilent Technologies, BGI Genomics, PerkinElmer, and Takara Bio
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global sequencing reagents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sequencing reagents market
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Library Preparation Reagents
- Template Preparation Reagents
- Sequencing Kits and Reagents
- Quality Control Reagents
- Purification and Cleanup Reagents
- Amplification Reagents
- Others
- Sequencing Type Insights (Revenue, USD Bn, 2021 - 2033)
- Next-Generation Sequencing (NGS)
- Sanger Sequencing
- Third-Generation Sequencing
- Workflow Insights (Revenue, USD Bn, 2021 - 2033)
- Sample Preparation
- Library Preparation
- Sequencing
- Data Validation and Quality Control
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Clinical Diagnostics
- Oncology and Cancer Research
- Reproductive Health and Genetic Screening
- Infectious Disease Testing
- Drug Discovery and Development
- Agrigenomics and Animal Research
- Forensic Research
- Others
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Hospitals and Diagnostic Laboratories
- Contract Research Organizations (CROs)
- Government and Public Health Laboratories
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Illumina
- Thermo Fisher Scientific
- QIAGEN
- Hoffmann-La Roche
- Pacific Biosciences
- Oxford Nanopore Technologies
- Agilent Technologies
- BGI Genomics
- PerkinElmer
- Takara Bio
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Sequencing Reagents Market, By Product Type
- Global Sequencing Reagents Market, By Sequencing Type
- Global Sequencing Reagents Market, By Workflow
- Global Sequencing Reagents Market, By Application
- Global Sequencing Reagents Market, By End User
- Global Sequencing Reagents Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
4. Global Sequencing Reagents Market, By Product Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Library Preparation Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Template Preparation Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Sequencing Kits and Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Quality Control Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Purification and Cleanup Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Amplification Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Sequencing Reagents Market, By Sequencing Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Next-Generation Sequencing (NGS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Sanger Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Third-Generation Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Sequencing Reagents Market, By Workflow, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Sample Preparation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Library Preparation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Data Validation and Quality Control
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Sequencing Reagents Market, By Application, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Clinical Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Oncology and Cancer Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Reproductive Health and Genetic Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Infectious Disease Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Agrigenomics and Animal Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Forensic Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Sequencing Reagents Market, By End User, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Hospitals and Diagnostics Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Government and Public Health Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
9. Global Sequencing Reagents Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sequencing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Workflow, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sequencing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Workflow, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sequencing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Workflow, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sequencing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Workflow, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sequencing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Workflow, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sequencing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Workflow, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Illumina
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QIAGEN
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hoffmann-La Roche
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pacific Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Oxford Nanopore Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BGI Genomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PerkinElmer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takara Bio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
